← Evidence map

ArticleSkin health and disease2025

Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany.

Luise Heinrich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany. | OpenQuestion